Literature DB >> 936207

Prenatal diagnosis and fetal pathology of Tay-Sachs disease.

S Higami, K Nishizawa, K Omura, K Sugimoto, G Isshiki.   

Abstract

In 6 cases of high risk pregnancies for Tay-Sachs disease, prenatal diagnosis was successfully carried out by examining hexosaminidase A activity in the supernatant of amniotic fluid and the uncultured and cultured amniotic fluid cells. In 5 out of 6 cases, the activity of hexosaminidase A was found to be within normal or heterozygous levels. They continued their pregnancies and were delivered of healthy children. In the remaining 1 case, the activity was undetected. Her pregnancy was terminated at the 23rd week of gestation. There was no activity of hexosamindase A in the brain and liver from the aborted fetus. A moderate increase in GM2 ganglioside was found in the brain. Electron-microscopic findings revealed membranous cytoplasmic bodies in the spinal ganglion cells as well as in the nerve cells of the retina. These biochemical and histological findings of Tay-Sachs fetus suggest that the disease proceeds early in fetal period. It was found that the cultured amniotic fluid cells was the most reliable material for the prenatal diagnosis of Tay-Sachs disease, because the values of hexoxaminidase A in the cultured cells were well in accord with those in serum from the consequently bord children. Hexosaminidase pattern in the supernatant of amniotic fluid on DEAE-cellulose columnchromatogram showed a distinct difference between homozygote, heterozygote and normal. This procedure also may be useful for prenatal diagnosis of Tay-Sachs disease.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 936207     DOI: 10.1620/tjem.118.323

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  2 in total

1.  Natural history of Tay-Sachs disease in sheep.

Authors:  Brett Story; Toloo Taghian; Jillian Gallagher; Jey Koehler; Amanda Taylor; Ashley Randle; Kayly Nielsen; Amanda Gross; Annie Maguire; Sara Carl; Siauna Johnson; Deborah Fernau; Elise Diffie; Paul Cuddon; Carly Corado; Sundeep Chandra; Miguel Sena-Esteves; Edwin Kolodny; Xuntian Jiang; Douglas Martin; Heather Gray-Edwards
Journal:  Mol Genet Metab       Date:  2021-08-21       Impact factor: 4.204

2.  Therapeutic advantages of combined gene/cell therapy strategies in a murine model of GM2 gangliosidosis.

Authors:  Davide Sala; Francesca Ornaghi; Francesco Morena; Chiara Argentati; Manuela Valsecchi; Valeria Alberizzi; Roberta Di Guardo; Alessandra Bolino; Massimo Aureli; Sabata Martino; Angela Gritti
Journal:  Mol Ther Methods Clin Dev       Date:  2022-03-16       Impact factor: 6.698

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.